184 related articles for article (PubMed ID: 31691172)
1. CDX-2 Expression in Esophageal Biopsies Without Goblet Cell Intestinal Metaplasia May Be Predictive of Barrett's Esophagus.
Saller J; Al Diffalha S; Neill K; Bhaskar RA; Oliveri C; Boulware D; Levine H; Kalvaria I; Corbett FS; Khazanchi A; Klapman J; Coppola D
Dig Dis Sci; 2020 Jul; 65(7):1992-1998. PubMed ID: 31691172
[TBL] [Abstract][Full Text] [Related]
2. Expression of resistin-like molecule beta in Barrett's esophagus: a novel biomarker for metaplastic epithelium.
Zheng L; Tong Q; Weng M; He J; Lv Q; Wu Z; Du Z; Mei H; Hou X
Dig Dis Sci; 2010 Jan; 55(1):32-9. PubMed ID: 19225886
[TBL] [Abstract][Full Text] [Related]
3. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
Groisman GM; Amar M; Meir A
Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
[TBL] [Abstract][Full Text] [Related]
4. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.
Tamagawa Y; Ishimura N; Uno G; Yuki T; Kazumori H; Ishihara S; Amano Y; Kinoshita Y
Lab Invest; 2012 Jun; 92(6):896-909. PubMed ID: 22449796
[TBL] [Abstract][Full Text] [Related]
5. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
6. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus.
Bansal A; McGregor DH; Anand O; Singh M; Rao D; Cherian R; Wani SB; Rastogi A; Singh V; House J; Jones PG; Sharma P
Dis Esophagus; 2014; 27(8):751-6. PubMed ID: 24165297
[TBL] [Abstract][Full Text] [Related]
7. Expression of CDX2 and MUC2 in Barrett's mucosa.
Steininger H; Pfofe DA; Müller H; Haag-Sunjic G; Fratianu V
Pathol Res Pract; 2005; 201(8-9):573-7. PubMed ID: 16259110
[TBL] [Abstract][Full Text] [Related]
8. CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.
Johnson DR; Abdelbaqui M; Tahmasbi M; Mayer Z; Lee HW; Malafa MP; Coppola D
World J Gastroenterol; 2015 Mar; 21(9):2770-6. PubMed ID: 25759548
[TBL] [Abstract][Full Text] [Related]
9. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.
Kunze B; Wein F; Fang HY; Anand A; Baumeister T; Strangmann J; Gerland S; Ingermann J; Münch NS; Wiethaler M; Sahm V; Hidalgo-Sastre A; Lange S; Lightdale CJ; Bokhari A; Falk GW; Friedman RA; Ginsberg GG; Iyer PG; Jin Z; Nakagawa H; Shawber CJ; Nguyen T; Raab WJ; Dalerba P; Rustgi AK; Sepulveda AR; Wang KK; Schmid RM; Wang TC; Abrams JA; Quante M
Gastroenterology; 2020 Aug; 159(2):575-590. PubMed ID: 32325086
[TBL] [Abstract][Full Text] [Related]
10. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
11. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
12. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
[TBL] [Abstract][Full Text] [Related]
13. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination.
Çoban Ş; Örmeci N; Savaş B; Ekiz F; Ensari A; Kuzu I; Palabıyıkoğlu M
Dis Esophagus; 2013; 26(2):189-96. PubMed ID: 22591041
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic versus histological diagnosis of Barrett's esophagus: a cross-sectional survey.
Irvanloo G; Fallahi B; Ensani F; Azmi M; Morteza A
Pol J Pathol; 2011 Sep; 62(3):152-6. PubMed ID: 22102072
[TBL] [Abstract][Full Text] [Related]
17. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
18. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
[TBL] [Abstract][Full Text] [Related]
19. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
Souza RF; Krishnan K; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
[TBL] [Abstract][Full Text] [Related]
20. Goblet cell mimickers in esophageal biopsies are not associated with an increased risk for dysplasia.
Younes M; Ertan A; Ergun G; Verm R; Bridges M; Woods K; Meriano F; Schmulen AC; Colman R; Johnson C; Barroso A; Schwartz J; McKechnie J; Lechago J
Arch Pathol Lab Med; 2007 Apr; 131(4):571-5. PubMed ID: 17425386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]